Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A
KNSA
Market Cap$1.9B
Close$
$-4.53
117.4% downside
Current Fair Value
117.4% downsideOvervalued by 117.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.90 Billion |
|---|---|
| Enterprise Value | $1.74 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.6 |
| Beta | 0.07 |
| Outstanding Shares | 72,647,121 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -111.56 |
|---|---|
| PEG | 1330.22 |
| Price to Sales | 5.21 |
| Price to Book Ratio | 4.34 |
| Enterprise Value to Revenue | 4.54 |
| Enterprise Value to EBIT | -66.41 |
| Enterprise Value to Net Income | -193 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data